Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Cell Mol Bioeng. 2016 May 26;9(4):496–508. doi: 10.1007/s12195-016-0448-5

Figure 6. 14E11, 1A6, and rivaroxaban did not affect local platelet aggregate formation under flow.

Figure 6

Recalcified whole blood was perfused over collagen-coated surfaces at 1000 s−1 shear rate. (A) Platelet aggregates formed on collagen surfaces in the presence of 14E11 (50 μg/ml), 1A6 (50 μg/ml) or rivaroxaban (100 nM). (B) Aggregate volume (left) and surface area (right) in the presence of 14E11 (top), 1A6 (middle) or rivaroxaban (bottom) at indicated concentrations. Images and histograms are representative from each 3 fields of view from two different blood donors. Scale bar = 20 μm.